CJC-1295 without DAC: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 180 community reports
- โข4 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Combination as Standard | CJC-1295 without DAC (Modified GRF 1-29) has been studied as a standalone GHRH analog. Published pharmacological data confirms its short half-life (~30 minutes) and pulsatile GH release pattern. | The community almost never uses Mod GRF 1-29 alone. It is nearly always combined with a GHRP, most commonly ipamorelin. The combination is considered the gold standard GH secretagogue protocol. | high While the GHRH + GHRP synergy concept has pharmacological support, the specific chronic combination protocol for body composition outcomes has not been clinically validated. |
| Saturation Dose Concept | Clinical studies used weight-based dosing. No published data specifically defines a receptor saturation threshold for subcutaneous administration in humans. | The community refers to 100 mcg as the saturation dose, meaning the amount believed to fully saturate the GHRH receptor without additional benefit from higher doses. This concept is widely accepted in the community. | moderate The 100 mcg saturation dose concept is community-derived. While it may approximate an effective dose based on pharmacological principles, it has not been validated by dose-response studies in humans. |
| Multiple Daily Injections | Published studies examined acute GH responses to single doses, not chronic multi-dose daily regimens. | Users commonly inject 2-3 times daily to create multiple GH pulses, mimicking the natural pulsatile pattern. Timing is structured around fasting windows. | moderate Multiple daily dosing is the community-standard optimization for pulsatile GH release, but has not been studied for chronic body composition outcomes. |
Compare these community approaches with published research findings.
Community Protocols
Saturation Dose Protocol (with Ipamorelin)
Popular- Route
- Subcutaneous
- Dose
- 100 mcg (combined with 100 mcg ipamorelin)
- Frequency
- 2-3 times daily
- Duration
- 8-16 weeks
The classic community protocol; 100 mcg of each peptide combined per injection, on empty stomach, typically AM fasted, post-workout, and pre-bed
Standard GHRH Protocol
Popular- Route
- Subcutaneous
- Dose
- 100-200 mcg
- Frequency
- 1-3 times daily
- Duration
- 8-12 weeks
Used standalone or combined with a GHRP; pre-bed injection most common for single daily dosing
Pre-Bed Only Protocol
Common- Route
- Subcutaneous
- Dose
- 200 mcg (with 200 mcg ipamorelin)
- Frequency
- Once daily before bed
- Duration
- 12+ weeks, 5 days on/2 days off
Simplified once-daily protocol targeting nocturnal GH pulse; common for anti-aging and general wellness goals
Post-Workout Pulse Protocol
Niche- Route
- Subcutaneous
- Dose
- 100-200 mcg
- Frequency
- Post-workout only (3-5 times per week)
- Duration
- 8-12 weeks
Targeted post-exercise dosing to enhance recovery; used by athletes and bodybuilders
Stacking Patterns
CJC-1295 No DAC + Ipamorelin
PopularThe gold standard GH secretagogue stack; GHRH + GHRP synergy for enhanced pulsatile GH release through complementary receptor activation
CJC-1295 No DAC + GHRP-2
CommonAlternative GHRH + GHRP combination; GHRP-2 produces stronger GH release than ipamorelin but with more appetite stimulation
CJC-1295 No DAC + Ipamorelin + BPC-157
CommonGH secretagogue foundation with healing peptide for comprehensive recovery from injuries while maintaining elevated GH output
CJC-1295 No DAC + Hexarelin
NicheMaximum GH release stack; hexarelin is among the most potent GHRPs but carries higher cortisol and prolactin elevation risk
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 180+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Peptides|CJC-1295 no DAC + ipamorelin experience reports and saturation dose discussions(accessed 2026-02-16)
- Reddit r/PeptideResearch|Mod GRF 1-29 protocol and stacking threads(accessed 2026-02-16)
- PeptideDosages.com|CJC-1295 No DAC 5mg Vial Dosage Protocol(accessed 2026-02-16)
- Peptides.org|CJC-1295 DAC vs No DAC Difference Guide(accessed 2026-02-16)
- Revolution Health|CJC-1295 With DAC vs Without DAC Differences and Benefits(accessed 2026-02-16)
- Alpha Rejuvenation|CJC-1295 Ipamorelin Dosage Protocols(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for CJC-1295 without DAC (Modified GRF 1-29). The information below is gathered from peptide research forums, Reddit communities, and self-experimenter reports. This is not clinical evidence and should not be used as medical guidance.
CJC-1295 without DAC is arguably the most popular GHRH analog in the peptide community, primarily used in combination with ipamorelin as the gold standard GH secretagogue protocol. Its short half-life and pulsatile GH release pattern are valued by community members who prefer mimicking natural GH physiology.
Understanding Protocol Divergence#
The Saturation Dose Concept#
One of the most distinctive community-derived concepts is the saturation dose of approximately 100 mcg. This refers to the amount believed to fully occupy available GHRH receptors, beyond which additional peptide provides diminishing returns. While this concept has a logical pharmacological basis (receptor occupancy principles), the specific 100 mcg threshold has not been established through formal dose-response studies in humans.
Mandatory Combination Protocol#
Unlike most peptides where solo use is common, CJC-1295 no DAC is almost never used alone in the community. The near-universal practice is combination with ipamorelin (or less commonly GHRP-2 or hexarelin). This stands in contrast to published research, which primarily examines the GHRH analog as a standalone agent.
Fasting Discipline#
The community places significant emphasis on injection timing relative to meals. The standard practice requires fasting for 1-2 hours before and 30-60 minutes after injection, based on the well-established principle that insulin and blood glucose suppress GH release. This creates a structured daily schedule, particularly for multi-dose protocols.
Commonly Reported Outcomes#
Community members frequently report the following when using CJC-1295 no DAC (typically combined with ipamorelin):
- Sleep quality: Improved sleep depth and more vivid dreams within 1-2 weeks
- Recovery: Enhanced workout recovery and reduced soreness at 2-4 weeks
- Body composition: Gradual improvements in lean mass and fat reduction over 2-4 months
- Skin quality: Improved skin elasticity and appearance over several months
- Tingling/numbness: Transient tingling in hands and feet shortly after injection (considered a sign of GH release by the community)
Important Caveats#
- These are self-reported outcomes without controls or blinding
- Most users combine with ipamorelin, making attribution to either peptide difficult
- The saturation dose concept and combination protocols are not clinically validated
- Product quality and purity vary between vendors
Reconstitution and Storage Practices#
Community reconstitution practices for CJC-1295 no DAC:
- Reconstitution: 1-2 mL bacteriostatic water per 2-5 mg vial
- Storage: Reconstituted solution refrigerated at 2-8 degrees C
- Shelf life: Most users report using within 2-3 weeks (shorter stability than DAC version)
- Injection volume: Typically 0.02-0.1 mL per injection with insulin syringe
- Note: Mod GRF 1-29 is considered more fragile than the DAC version and should be handled gently during reconstitution
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About CJC-1295 without DAC
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.